A group of researchers from the Technion and the United States reports a breakthrough in MRI scanning in a paper published in Nature Communications. The researchers developed an innovative method that ...
Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer derived from screening ...
Enhertu showed better outcomes in HR-positive, HER2-negative breast cancer, while Trodelvy was more effective in HR-negative, HER2-null tumors when used first. Real-world data from over 4,000 patients ...
Community-treated HER2-low mBC patients were older (mean 63.5 years), with impaired performance status (22.7%) and comorbidities (39.3%), suggesting broader clinical complexity than trial cohorts.
The precise detection of breast cancer in histopathological images remains a critical challenge in computational pathology, where accurate tissue segmentation significantly enhances diagnostic ...
Stakeholder Perspectives on Provider-Initiated Clinical Breast Examination and Patient Navigation in Ethiopian General Hospitals: Situational Analysis for Implementation Study Biomarkers estrogen ...
Oranus Mohammadi, MD, discusses the emerging applications of circulating tumor DNA (ctDNA) in breast cancer care and emphasizes the importance of clear communication to help patients navigate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results